Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Febuxostat Related Intermediates: Febuxostat CAS 144060-53-7 Ethyl 2-Chloroacetoacetate CAS 609-15-4 4-Hydroxythiobenzamide CAS 25984-63-8 Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3 Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7 Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2 Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4 Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5| Item | Specifications |
| Appearance | Light Yellow to Yellow Powder or Crystals |
| Purity / Analysis Method | >99.0% (HPLC) |
| Water Content (K.F) | <0.50% |
| Residue on Ignition | <0.50% |
| Total Impurities | <1.00% |
| 1 H NMR Spectrum | Consistent With Structure |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Febuxostat (CAS: 144060-53-7) |
Description:
Specifications:
Package & Storage:
| Chemical Name | Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate |
| Synonyms | Febuxostat Formyl Hydroxy Ethyl Ester; Febuxostat Impurity 2; Febuxostat Intermediate 4 |
| CAS Number | 161798-03-4 |
| CAT Number | RF-PI1856 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C18H21NO4S |
| Molecular Weight | 347.43 |
| Density | 1.183 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161798-03-4) is an intermediate or impurity of Febuxostat (CAS: 144060-53-7). Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.
